BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21382093)

  • 21. [Report of seven cases of clear-cell meningioma and a literature review].
    Rousselot C; Francois P; Jan M; Bergemer AM
    Ann Pathol; 2010 Apr; 30(2):73-82. PubMed ID: 20451062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdoid meningioma: intraoperative diagnosis using smear preparation.
    Kirby PA
    Diagn Cytopathol; 2003 Nov; 29(5):292-6. PubMed ID: 14595799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial papillary meningioma: a clinicopathologic study of 30 cases at a single institution.
    Wang XQ; Chen H; Zhao L; Li ST; Hu J; Mei GH; Jiang CC
    Neurosurgery; 2013 Nov; 73(5):777-90; discussion 789. PubMed ID: 23921710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
    Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
    Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. June 2004: a male in his late 60s with recurrent extracerebral tumor.
    Mawrin C; Hahne R; Scherlach C; Kirches E; Dietzmann K
    Brain Pathol; 2004 Oct; 14(4):457-9. PubMed ID: 15605995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant meningioma with rhabdoid transformation.
    Lee WH; Chen A; Chao DG; Harn HJ; Lin SZ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):492-7. PubMed ID: 10925541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdoid meningioma presenting with subependymal and diffuse meningeal involvement but no mass lesion.
    Ahmad KE; Al-Jahdhami S; Ahmad O
    J Clin Neurosci; 2010 Dec; 17(12):1581-2. PubMed ID: 20800496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clear cell meningioma with anaplastic features: case report and review of literature.
    Tong-tong W; Li-juan B; Zhi L; Yang L; Bo-ning L; Quan H
    Pathol Res Pract; 2010 May; 206(5):349-54. PubMed ID: 19857933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy.
    Shimada S; Ishizawa K; Hirose T
    Pathol Int; 2005 Jan; 55(1):1-7. PubMed ID: 15660696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between malignant subtypes of meningioma and clinical outcome.
    Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
    J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
    Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
    Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recurrent meningioma with malignant transformation: a case which changed from meningothelial type to papillary type].
    Yamazaki Y; Kawano N; Suwa T; Ito H; Yada K; Kuwao S
    No Shinkei Geka; 1994 Mar; 22(3):285-9. PubMed ID: 8133973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Rhabdoid meningioma" lacking malignant features. Report of two cases.
    Cooper WA; Shingde M; Lee VK; Allan RS; Wills EJ; Harper C
    Clin Neuropathol; 2004; 23(1):16-20. PubMed ID: 14986929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraparenchymal recurrence of a dural meningioma: association with rhabdoid alterations with aggressive biological and clinical behaviour.
    Lofrese G; Della Pepa GM; Sabatino G; Esposito G; Puca A; Albanese A
    Br J Neurosurg; 2011 Jun; 25(3):324-6. PubMed ID: 21158508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdoid and papillary meningioma with leptomeningeal dissemination.
    Santhosh K; Kesavadas C; Radhakrishnan VV; Thomas B; Kapilamoorthy TR; Gupta AK
    J Neuroradiol; 2008 Oct; 35(4):236-9. PubMed ID: 18325590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.